Oxford University Press

SHERPA: Yellow

People

  1. Dogan
    Dogan
  2. Xiao
    Xiao
  3. Budhu
    Budhu
  4. Chandarlapaty
    Chandarlapaty
  5. Drilon
    Drilon
  6. Grommes
    Grommes
  7. Gulati
    Gulati
  8. Mango
    Mango
  9. Mellinghoff
    Mellinghoff
  10. Schrag
    Schrag

Groups

  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (23)
  3. GSK Faculty (20)
  4. Population Sciences Research Program (16)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  7. Human Oncology and Pathogenesis Program (10)
  8. Radiology, Department of (9)
  9. Survivorship Research (9)
  10. Tow Center for Developmental Oncology (TCDO) (9)
Search Within
  1. "Review"
Formats
  1. Review (89)
Groups
  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (23)
  3. GSK Faculty (20)
  4. Population Sciences Research Program (16)
  5. Department of Pathology and Laboratory Medicine (11)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)

More Groups

People
  1. Ahmet Dogan (6)
  2. Amy Duffield (5)
  3. Wenbin Xiao (5)
  4. Amitabh Gulati (4)
  5. Jorge Reis-Filho (4)
  6. Alexander Drilon (3)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (19)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (19)

More Years

Publications
  1. Annals of Oncology (16)
  2. Neuro-Oncology (14)
  3. American Journal of Clinical Pathology (7)
  4. Journal of Breast Imaging (7)
  5. JNCI: Journal of the National Cancer Institute (5)
  6. Neuro-Oncology Practice (5)

More Publications

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Proceedings of the 1st biannual Bridging the Gaps in Lung Cancer conference
    Review

    Florez, N.; Patel, S. P.; Wakelee, H.; Bazhenova, L.; Massarelli, E.; Salgia, R.; Stiles, B.; Peters, S.; Malhotra, J.; Gadgeel, S. M.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment
    Review

    Janelsins, M. C.; Van Dyk, K.; Hartman, S. J.; Koll, T. T.; Cramer, C. K.; Lesser, G. J.; Barton, D. L.; Mustian, K. M.; Wagner, L.; Ganz, P. A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Financial challenges of being on long-term, high-cost medications
    Review

    Elshiekh, C.; Rudà, R.; Scheffer Cliff, E. R.; Gany, F.; Budhu, J. A.
    Neuro-Oncology Practice (2025)

    Fulltext@MSK | Save
  • Symptom management in isocitrate dehydrogenase mutant glioma
    Review

    Walbert, T.; Avila, E. K.; Boele, F. W.; Hertler, C.; Lu-Emerson, C.; van der Meer, P. B.; Peters, K. B.; Rooney, A. G.; Templer, J. W.; Koekkoek, J. A. F.
    Neuro-Oncology Practice (2025)

    Fulltext@MSK | Save
  • Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
    Review

    Zhang, T.; Tan, A.; Shah, A. Y.; Iyer, G.; Morris, V.; Michaud, S.; Sridhar, S. S.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Lung cancer research and treatment: Global perspectives and strategic calls to action
    Review

    Meyer, M. L.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. C.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Enhancing neuro-oncology care through equity-driven applications of artificial intelligence
    Review

    Mehari, M.; Sibih, Y.; Dada, A.; Chang, S. M.; Wen, P. Y.; Molinaro, A. M.; Chukwueke, U. N.; Budhu, J. A.; Jackson, S.; McFaline-Figueroa, J. R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Breast cancer and cardiovascular health
    Review

    López-Fernández, T.; Marco, I.; Aznar, M. C.; Barac, A.; Bergler-Klein, J.; Meattini, I.; Scott, J. M.; Cardinale, D.; Dent, S.
    European Heart Journal (2024)

    Fulltext@MSK | Save
  • The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
    Review

    van den Bent, M. J.; French, P. J.; Brat, D.; Tonn, J. C.; Touat, M.; Ellingson, B. M.; Young, R. J.; Pallud, J.; von Deimling, A.; Sahm, F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions
    Review

    Wilcox, J. A.; Chukwueke, U. N.; Ahn, M. J.; Aizer, A. A.; Bale, T. A.; Brandsma, D.; Brastianos, P. K.; Chang, S.; Daras, M.; Forsyth, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save